SARS-CoV-2 IgG eCLIA 50 Test

Immunoassay for in vitro quantify determination of SARS-CoV-2 IgG antibodies in human serum and/or plasma, which is clinically used for auxiliary diagnosis of coronavirus disease COVID-19.